GlassScriptPhysician profile
Laura A Merkel
NPI 1588988018
$3,188.03
in general payments reported to CMS, 2019-2025
27 companies · $1,022 in 2025
The $1,022 reported for 2025 was more than what 91% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $281 · 2020: $145 · 2021: $338 · 2022: $319 · 2023: $597 · 2024: $486 · 2025: $1,022.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,005 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,005.42 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $395.48 | 2019-2023 | |
| Astellas Pharma US INC | $323.30 | 2023-2025 | Veozah |
| Sumitomo Pharma America, INC. | $284.67 | 2023-2025 | Myfembree, Gemtesa |
| Sage Therapeutics, LLC | $276.57 | 2021-2025 | Zurzuvae |
| Exeltis, USA INC. | $264.08 | 2020-2025 | Slynd |
| Ethicon US, LLC | $248.10 | 2025 | Vistaseal, Ethicon, Evarrest |
| Organon LLC | $173.26 | 2021-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $141.23 | 2019-2025 | |
| Hologic Sales and Service, LLC | $130.61 | 2021-2025 | Aptima |
| Pfizer INC. | $114.12 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $94.74 | 2019-2024 | Gardasil 9, Gardasil |
| Aspira Women'S Health INC | $85.95 | 2020-2021 | |
| Renovia INC | $82.79 | 2019 | |
| Amgen INC. | $82.04 | 2020-2025 | Evenity, Prolia |
| Amag Pharmaceuticals, INC. | $70.45 | 2019-2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $70.12 | 2024-2025 | |
| Millicent US INC | $66.65 | 2023-2025 | Intrarosa, Femring, Femlyv |
| Therapeuticsmd, INC. | $56.33 | 2019-2021 | |
| Myovant Sciences INC. | $45.63 | 2022 | |
| Smith+Nephew, INC. | $44.60 | 2023 | Acticoat 4" X 4", Pico 7 |
| Scynexis, INC. | $25.52 | 2022 | |
| Novo Nordisk INC | $25.38 | 2025 | |
| Avion Pharmaceuticals | $22.65 | 2021 | |
| Shield Therapeutics INC | $21.42 | 2024 | |
| Meditrina | $14.32 | 2025 | |
| Coopersurgical, INC. | $14.06 | 2024 | Paragard T 380a |
| Exact Sciences Corporation | $13.96 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Merkel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.